Inhibition of gene associated with Dyslipidemia and Antioxidative Effect of ,  and (ACR) on HepG2 cell model

Jiyun Cha; Ho-ryong Yoo; Yoon-sik Kim; In-chan Seol; Hyun-kyung Jo; Cha, Jiyun; Yoo, Ho-ryong; Kim, Yoon-sik; Seol, In-chan; Jo, Hyun-kyung

doi:10.13048/jkm.17024

JKM > Volume 38(3); 2017 > Article

Cha, Yoo, Kim, Seol, and Jo: Inhibition of gene associated with Dyslipidemia and Antioxidative Effect of Artemisia iwayomogi, Curcumae Radix and Raphani Semen(ACR) on HepG2 cell model

Original Article

The Journal of Korean Medicine 2017; 38(3): 43-58.

Published online: September 30, 2017

DOI: https://doi.org/10.13048/jkm.17024

Inhibition of gene associated with Dyslipidemia and Antioxidative Effect of Artemisia iwayomogi, Curcumae Radix and Raphani Semen(ACR) on HepG2 cell model

Jiyun Cha, Ho-ryong Yoo, Yoon-sik Kim, In-chan Seol, Hyun-kyung Jo

Dept. of Internal Medicine, College of Korean Medicine, Daejeon University

Correspondence to：조현경(Jo Hyun-kyung) Dept. of Internal Medicine, Daejeon Oriental Hospital of Daejeon University 34929, 176-9 Daeheung-ro, Jung-gu, Daejeon, South Korea Tel：+82-42-229-6924, Fax：+82-42-254-3403, E-mail : brillijo@hanmail.net

Received August 7, 2017 Revised September 12, 2017 Accepted September 12, 2017

Abstract

Objectives

We performed this study to evaluate the antioxidative and hypolipidemic effect of Artemisia iwayomogi (韓茵蔯), Curcuma longa L. (鬱金) and Raphanus sativus L. (蘿葍子) (ACR).

Method

We enriched Artemisiae Capillaris, Curcumae Longae and Raphani Semen compound with alcohol. ACR extract is treated to HepG2 cell. Cell groups are devided into 3 groups: normal, control and ACR treated group. We measured polyphenol, flavonoids, DPPH and ABTS radical scavenging activity, ROS, glutathione, GSH peroxidase, GSH reductase, SOD, catalase, free fatty acid, lipid peroxidation and suppression of ACAT1 and HMG-CoA reductase expression on mRNA level.

Results

ACR contained polyphenol and flavonoids and increased GSH significantly in HepG2 cell.
ACR increased GPx, GR, and catalase activity significantly in HepG2 cell.
ACR increased DPPH and ABTS radical scavenging activity significantly in HepG2 cell and decreased ROS.
ACR decreased free fatty acid and MDA significantly in HepG2 cell.
ACR suppressed ACAT1 and HMG-CoA reductase expression on mRNA level in HepG2 cell.

Conclusion

This study suggests that ACR has antioxidative and hypolipidemic effect and might be effective in prevention and treatment of dyslipidemia.

Keywords: Dyslipidemia, Hyperlipidemia, Antioxidant, Artemisia iwayomogi, Curcumae Radix, Raphani Semen

Fig. 1

Cell viability of HepG2 cells treated ACR extract.

Cell viability was calculated as percentage versus normal. The result were presented by the mean ± S.D from three independent experiments

Fig. 2

Effect of ACR extract on total GSH contents in HepG2 cells.

Total GSH contents were calculated using GSH standard curve. The result were presented by the mean ± S.D from three independent experiments (Significance of results, ***: p<0.001 compare to control). Normal; non-treated HepG2 cells. Control; 1 mM H2O2-treated HepG2 cells.

Fig. 3

Effect of ACR extract on GPx, GR, SOD and Catalase activity in HepG2 cells.

(A) GPx activity was calculated using NADPH standard curve.

(B) GR activity was calculated using TNB standard curve.

(D) Catalase activity was calculated using H₂O₂ standard curve.

The result were presented by the mean ± S.D from three independent experiments (Significance of results, **: p<0.01, ***: p<0.001 compare to control). Normal; non-treated HepG2 cells. Control; 1 mM H₂O₂-treated HepG2 cells.

Fig. 4

DPPH and ABTS radical scavenging activity of ACR extract and effect of ACR extract on ROS production in HepG2 cells.

(A) DPPH radical scavenging activity of ACR extract comparing to ascorbic acid.

(B) ABTS radical scavenging activity of ACR extract comparing to ascorbic acid.

(C) Effect of ACR extract on ROS production in HepG2 cells. Level of ROS was calculated as percentage versus control. Normal; non-treated HepG2 cells. Control; 1 mM H₂O₂-treated HepG₂ cells.

The result were presented by the mean ± S.D from three independent experiments (Significance of results, ***: p<0.001 compare to control).

Fig. 5

Effect of ACR extract on free fatty acid contents and MDA in HepG2 cells.

(A) Free fatty acid contents were calculated using palmitate standard curve. Normal ; non-treated HepG2 cells, Control ; 0.5 mM FAs (palmitate;oleic acid, 6:4)-treated HepG2 cells.

(B) Lipid peroxidation (MDA) was calculated using MDA standard curve. Normal ; non-treated HepG2 cells, Control ; 1 mM H2O2-treated HepG2 cells.

The result were presented by the mean ± S.D from three independent experiments (Significance of results, **: p<0.01, ***: p<0.001 compare to control).

Fig. 6

Effect of ACR extract on ACAT1 and HMG-CoA reductase mRNA expression in HepG2 cells.

ACAT1, HMG-CoA reductase and β-actin mRNA expression were determined using RT-PCR. Normal ; non-treated HepG2 cells, Control ;0.5 mM FAs (palmitate:oleic acid, 6:4)-treated HepG2 cells.

Table 1

The Sequences of Primers in This Study

Primer	F/R	Sequences	Cycle	Annealing (°C)
ACAT1	F	5′-AGCAGAGGCAGAGGAATTGA-3′	35	60
ACAT1	R	5′-GCACACCTGGCAAGATGGAG-3′	35	60

HMG-CoA reductase	F	5′-TTCGGTGGCCTCTAGTGAGA-3′	38	60
HMG-CoA reductase	R	5′-TGTGAGTTGGAACTGAGGGC-3′	38	60

β-actin	F	5′-TGTCACCAACTGGGACGATA-3′	35	56
β-actin	R	5′-GGGGTGTTGAAGGTCTCAAA-3′	35	56

참고문헌

1. Statistics Korea. 2015 Cause of death statistics. 2016.

2. Department of circulatory internal medicine, college of oriental medicine. Korean medicine cardiology and neurology. 4th ed. Seoul: Gunja publisher;2010. p. 184–189.

3. Korea national health and nutrition examination survey. 2014 National health statistics. Seajong: Ministry of Health and Welfare;2015. p. 36–57.

4. Habukuihakwon. Youngchu-kyungkyosuk. Beijing: Inminwisheng publisher;1982. p. 161

5. Kim HT, Kim YS, Seol IC, Yoo HR. The Effects of an Extract of Artemisiae Capillaris, Curcumae Longae, and Crataegi Fructus (IUS) on Anti-hyperlipidemia and Anti-oxidation in db/db Mouse Model. J Int Korean Med. 2016; 37:3. 467–83.

6. Lee SJ. Protective effect of a extract of Artemisia iwayomogi Kitamura plus Curcuma longa Linne. against Hyperlipidemia and Obesity in High Fat-Diet Mice Model. Daejeon University;Daejeon, Korea: 2012.

7. Lee JM, Seo BI, Park JH, Roh SS. Effects of water extracts from Phyllostachys Folium on hyperlipidemia and liver damage induced by alcohol. Kor J Herbology. 2011; 26:3. 31–6.

8. Moussavi NGV, Receveur O. Could the quality of dietary fat, and not just its quantity, be related to risk of obesity? Obesity (Silver Spring). 2008; 16:7–15.

9. Shehzad AHT, Subhan F, Lee YS. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr. 2011; 50:151–61.

10. Sekiya MHA, Touyama M, Sakamoto K. Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells. Biochem Biophys Res Commun. 2008; 375:602–7.

11. Kurata MSM, Agar NS. Antioxidant systems and erythrocyte life-span in mammals. Comp Biochem Physiol B. 1993; 106:477–87.

12. Shon MS, Kim GN. Anti-oxidant and anti-obese activities of turmeric(Curcuma longa L.) extract in 3T3-L1 cells. Kor J Aesthet cosmetol. 2014; 12:2. 169–75.

13. Kim MS, Chun SS, Choi JH. Effects of Turmeric (Curcuma longa L.) on Antioxidative Systems and Oxidative Damage in Rats Fed a High Fat and Cholesterol Diet. The J of the Korean Society of Food Science and Nutrition. 2013; 42:4. 570–6.

14. Jung SH, Chang CS, Ko KH. Physiological Effects of Curcumin Extracted by Supercritical Fluid from Turmeric(Curcuma longa L). Korean J of Food Science and Technology. 2004; 36:2. 317–20.

15. Zhang MF, Shen YQ. Antidiarrheal and antiinflammatory effects of sinapine. Pharmacology and Clinics of Chinese Materia Medica. 1996; 29–31.

16. Matth B. Antioxidant activity of extracts obtained from residues of different oilseeds. J of Agricultural and Food Chemistry. 2002; 50:12. 3444–52.

17. Yang CY, He L. Neuroprotective effects of sinapine on PC12 cells apoptosis induced by sodium dithionite. Chinese J of Natural Medicines. 2008; 6:3. 205–9.

18. Jackson S, Singletary K. Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J of Nutrition. 2004; 134:9. 2229–36.

19. Ramirez M, Singletary K. Regulation of estrogen receptor α expression in human breast cancer cells by sulforaphane. J of nutritional biochemistry. 2009; 20:3. 195–201.

20. Iv’anovics G, Horv’ath S. Raphanin. An antibacterial principle of the radish (Raphanus sativus). Nature. 1947; 160:4061. 297–8.

21. Kim JY. The Effects of Raphani Semenon Experimental Mouse Model of Obese diabete. Dongshin University;Naju, Korea: 2012.

22. Daegu Haany University Education-industrial Complex. matirial for treatment and protection of hyperlipidemia or obesity containing Raphanus sativus L. extract. 2008.

23. Castro-Torres IG, Naranjo-Rodríguez EB, Domínguez-Ortíz MÁ, Gallegos-Estudillo J, Saavedra-Vélez MV. Antilithiasic and hypolipidaemic effects of Raphanus sativus L. var. niger on mice fed with a lithogenic diet. BioMed Research International. 2012.

24. Gutfinger T. Polyphenols in olive oils. J of the American Oil Chemists Society. 1981; 58:11. 966–8.

25. Nieva M, Isla M, Sampietro A, Vattuone M. Comparison of the free radical -scavenging activity of propolis from several regions of Argentina. J of ethnopharmacology. 2000; 71:1. 109–14.

26. Kim BM, Jung JH, Kim DS, Kim YM, Jeong IH. Inhibitory activity of intracellular lipis accumulation by various marine extracts in HepG2 cells. Korean J Food Sci Technol. 2012; 44:362–6.

27. Ito T, Ikeda U. Infammatory cytokines and cardiovascular disease. Curr Drug Targets Inflamm Allergy. 2003; 2:257–65.

28. Bratus VV, Talaieva TV, Radalovska NV. The Role of a Systemic Inflammatory Process in The Atherogenic Modification of Lipoproteins and the Development of Hypercholesterolemia. Fiziol Zh. 1999; 45:40–9.

29. Tobert JA. Lovastatin and beyond: the history of the HMG CoA reductase inhibitors. Nat Rev Drug Discov. 2003; 2:517–526.

30. Kim SH. Drug treatment of dyslipidemia. J of the Korean Medical Association. 2016; 59:5. 366–73.

31. Cho MK, Noh KH, Kim JJ, Song YS. Anti-atherogenic effect of green tea product through hypolipidemic and anti-oxidative action in ovariectomized rats. J of the Korean Society of Food Science and Nutrition. 2007; 36:10. 1263–70.

32. Jung SH, Lee KT, Ann HS, Lee JY, Choi JW, Kim DG. Hypolipidemic and Antioxidative Effects of Bangpoongtongsungsankamibang on Diet-Induced Obesity Rats. Kor J Pharmacogn. 2006; 37:3. 190–5.

33. Hwang WK, Kim DH. Study on the Effect of Injinwieryungtang(IJWRT) on hyperlipidemia. J of Korean medicine research institute, Daejeon University. 2005; 14:2. 71–85.

34. Kim CY. Anti-hyperlipidemic Effect of Samhwangsasim-tanggamibang in High-cholesterol Diet induced Rat Model. Sangji University;Wonju, Korea: 2016.

35. Lee YJ, Son YJ, Lee ES, Park JS, Kim SG. Effects of Coicis Semen on the Hyperlipidemia in Rat. Kor J Herbology. 2004; 19:3. 129–36.

36. The Complilation Committee of the Korean Medicine College. Herbology. 2nd ed. Seoul: Yeonglim-sa;2010. p. 369–453.

37. Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: Role of lipid peroxidation, DNA damage, and repair. Langenbeck Arch Surg. 2006; 391:499–510.

38. Zheng W, Wang SY. Antioxidant activity and phenolic compounds in selected herbs. J Agric Food Chem. 2001; 49:5165–70.

39. Mayer AM, Harel E. Polyphenol oxidases in plants. Phytochemistry. 1979; 18:2. 193–215.

40. Winterbourn CC. Comparative reactivities of various biological compounds with myeloperoxidase -hydrogen peroxide-chloride, and similarity of oxidant to hypochlorite. Biochimica et Biophysica Acta (BBA)-General Subjects. 1985; 840:2. 204–10.